Kenya is set to roll out the long-acting injectable HIV Pre-Exposure prophylaxis (PrEP) Lenacapavir by January 2026 following its approval by the World Health Organization.In a statement, Health ...

A University of Colorado professor who experienced a funding freeze firsthand this year expressed relief at the program's preservation.

Kenya is set to introduce a revolutionary injectable HIV prevention drug, Lenacapavir, becoming one of nine African nations ...

These are the words of Rogers Omollo, founder and CEO of Activate Action – a youth-led non-profit organisation that supports ...

Kenya has been selected as one of the 9 early adopter countries for the rollout of Lenacapavir (LEN), a long-acting ...

The third study, Twiga , is an ongoing five-year observational study tracking comorbidities in both HIV-positive and HIV-negative individuals aged 60 and above. It was initiated to better understand ...

HIV and TB in Kenya When the immune system is weakened by the AIDS virus, people become vulnerable to many other infections. In parts of the world where both TB and AIDS are widespread, the number ...

Kenya requires Sh 5.24 billion for the 2024/2025 fiscal year and Sh 13.5 billion for 2025/2026 to maintain its current HIV response. Of these, Sh 1.2 billion will be used for distributing supplies ...